Furthermore, resultsfrom both clinicaltrialsandanimalstudiesindicate thatthesecomplicationsmightprogressdespiteglycemiccontrol, a phenomenontermedmetabolicmemory.
But the bigger challenge for many of these compounds is that, despite being in the midst of major phase 3 trials, it is not at all clear that they work.